Supporting progress & translation of gene & cell therapies
The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.
Vote Now
BSGCT is directed and run by a Board of volunteers, who are vital in deciding the strategic direction of the society. There are currently two Board vacancies to be filled. The call for nominations to the Board has closed, and you are now able to vote for your preferred candidates.
You have until 4pm on Thursday 19th June to vote for your representatives on the BSGCT Board, who will serve a 3 year term. To find more information on the nominees and cast your vote, you need to log in to your BSGCT online account.


The British Society for Gene and Cell Therapy (BSGCT) serves as a collaborative platform to advance Gene and Cell Therapy (GCT) in the UK.
We proactively foster cooperation among stakeholders, including the public, patients, scientists, companies, government, and media to support the optimal development of GCT technologies and therapies.
Our charity is managed by volunteer members via an Elected-Board and Sub-Committees. We rely on the crucial support of our sponsors and members and invite you to get involved.
BSGCT News and Opportunities
Researcher Spotlight
Biography: I am a clinician in Ear, Nose & Throat surgery in London, and I am currently taking time out…
BSGCT Board Voting Now Open
Dear Member, We are pleased to announce that voting is now open to elect two new Board members to the…
Researcher Spotlight: Gabriele Gelezauskaite
Biography: I am a final year iCASE BBSRC AstraZeneca-funded PhD student at the University of Sheffield in Professor Barbaric’s lab,…